BCRX BioCryst Pharmaceuticals, Inc. Net earnings per share growth forecast for next year
BioCryst stable income is based on the patent protection of its angioedema drug until the end of the decade. Shifting analyst expectations for n+1 EPS growth confirm the company's resilience, where 124.90 shows the value of this parameter. Business development relies on global medical partnerships and the robotization of new inhibitor discovery to automate laboratory tests.
BCRX (biocryst.com): analytical breakdowns and indicator data
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital BioCryst|BCRX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity BioCryst Pharmaceuticals|BCRX - Company Cumulative Debt|Debts to Book Capitalization BioCryst|BCRX - Company Long-Term Liabilities|Company Short-Term Debt BioCryst|Quick Liquidity Indicator biocryst.com
- earnings and valuation multiples information:
BCRX - Company Net Income|Expected Profit BioCryst|BCRX - Business Payback Period|Projected Price to Earnings BioCryst|BCRX - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple BioCryst|BCRX - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) BioCryst|BCRX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months biocryst.com|BCRX - Earnings per share increase in current year|Expected earnings per share growth for next year BioCryst
Fundamental company analysis:BioCryst Pharmaceuticals Inc, BCRX
This indicator mathematically aggregates analysts' consensus net income forecasts, filtering out market noise to identify the true earnings trajectory. The forward earnings per share trend reflects the stability of insurance fund payments for rare pathology therapies, allowing investors to assess the resilience of BioCryst (BCRX) cash flows in the face of potential regulatory risks or sudden market shocks.
Analysis of competing companies
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|GRFS: Net earnings per share growth forecast for next year|ADPT: Earnings growth forecast for next year|CLDX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aurinia Pharmaceuticals Inc.|Expected net earnings per share growth next year Vera Therapeutics Inc VERA|Earnings growth forecast for next year DNTH|Expected earnings per share growth for next year Pharvaris Pharma PHVS|Net earnings per share growth forecast for next year AbCellera Biologics ABCL|Expected earnings per share trend next year TRML|PGEN: Expected earnings per share growth for next year|Expected net earnings per share growth next year Pharming Group NV|Nektar (NKTR) - Net earnings per share growth forecast for next year|UPB - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year ZBIO|IMNM (immunome.com) - Projected earnings per share increase next year|Earnings growth forecast for next year GOSS|Net earnings per share growth forecast for next year KALV (KalVista Pharma)|Earnings growth forecast for next year SEPN (Septerna Corp)|PVLA - Expected earnings per share growth for next year|SVRA - Net earnings per share growth forecast for next year|Expected earnings per share trend next year RIGL (rigel.com)|ANAB (AnaptysBio) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year ATXS|Net earnings per share growth forecast for next year enGene Bio|RAPT Therapeutics Inc. - Net earnings per share change forecast for next year|Earnings growth forecast for next year JBIO|ACRS (aclaristx.com) - Expected earnings per share trend next year|Earnings growth forecast for next year KYTX (Kyverna Therapeutics, Inc.)|Earnings growth forecast for next year Tiziana Life Sciences Ltd. TLSA|CABA - Net earnings per share growth forecast for next year|Expected earnings per share trend next year VTYX (Ventyx Biosciences, Inc)|Theratechnologies Inc. (THTX) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year avalotx.com|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Agenus, Inc.|Expected earnings per share growth for next year CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Expected earnings per share trend next year|Earnings growth forecast for next year ATYR (aTyr Pharma, Inc.)|Consensus forecast of earnings per share growth for next year Adagene Inc (ADAG)|IMA - Net earnings per share growth forecast for next year|Shattuck Labs, Inc. (STTK) - Expected earnings per share growth for next year|equilliumbio.com (EQ) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Connect Biopharma Holdings Limited|Expected earnings per share growth for next year IMUX|Earnings growth forecast for next year Atara Biotherapeutics Inc|Net earnings per share growth forecast for next year InflaRx N.V. (IFRX)|X4 Pharmaceuticals Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year ACET (Adicet Bio, Inc.)|Celularity Inc (CELU) - Expected net earnings per share growth next year|INmune Bio, Inc. - Earnings growth forecast for next year|BRNS: Net earnings per share growth forecast for next year|KZR: Earnings growth forecast for next year|SABS - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Akari Therapeutics plc|Expected net earnings per share growth next year Enlivex Therapeutics, Ltd. ENLV|Earnings growth forecast for next year QTTB|Expected earnings per share growth for next year geovax.com GOVX|Net earnings per share growth forecast for next year Edesa Biotech EDSA|Expected earnings per share trend next year IBIO|CARM: Expected earnings per share growth for next year|Expected net earnings per share growth next year XTL Bio|boltbio.com (BOLT) - Net earnings per share growth forecast for next year|HCWB - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year APVO|AIM (AIM ImmunoTech, Inc.) - Projected earnings per share increase next year|Earnings growth forecast for next year ADTX|Net earnings per share growth forecast for next year GRI (GRI Bio Corporation)|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc.)|HIND - Expected earnings per share growth for next year|REVB - Net earnings per share growth forecast for next year|Expected earnings per share trend next year INDP (Indaptus Therapeutics Inc)|SCNI (Scinai) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CALI|Net earnings per share growth forecast for next year Affimed NV|Allakos Therapeutics - Net earnings per share change forecast for next year|Earnings growth forecast for next year HOOK|IGMS (igmbio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ITOS (iTeos)|Earnings growth forecast for next year Ocean Biomedical Corp OCEA|TCBP - Net earnings per share growth forecast for next year|Expected earnings per share trend next year THRD (thirdharmonicbio.com)
